Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | KULR | Common Stock | 50K | Nov 1, 2022 | Direct | F1 |
Id | Content |
---|---|
F1 | Effective as of November 1, 2022, Dr. Walker was appointed Chief Technology Officer of the Issuer. Prior to such appointment, Dr. Walker joined the Issuer, in March 2022, as Director of Engineering and in connection with such employment, Dr. Walker was granted a restrict stock award ("RSA") of 50,000 shares of the Issuer's common stock. The RSA is scheduled to vest in four equal annual installments (the first vesting to occur on April 13, 2023). The beneficial ownership set forth in Column 2 includes the shares underlying the RSA grant. However, none of the shares thereunder are expected to vest within 60 days of this Form 3. |